Correlation Between Assertio Therapeutics and Alvotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Assertio Therapeutics and Alvotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Assertio Therapeutics and Alvotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Assertio Therapeutics and Alvotech, you can compare the effects of market volatilities on Assertio Therapeutics and Alvotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Assertio Therapeutics with a short position of Alvotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Assertio Therapeutics and Alvotech.

Diversification Opportunities for Assertio Therapeutics and Alvotech

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Assertio and Alvotech is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Assertio Therapeutics and Alvotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alvotech and Assertio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Assertio Therapeutics are associated (or correlated) with Alvotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alvotech has no effect on the direction of Assertio Therapeutics i.e., Assertio Therapeutics and Alvotech go up and down completely randomly.

Pair Corralation between Assertio Therapeutics and Alvotech

Given the investment horizon of 90 days Assertio Therapeutics is expected to generate 2.19 times more return on investment than Alvotech. However, Assertio Therapeutics is 2.19 times more volatile than Alvotech. It trades about 0.04 of its potential returns per unit of risk. Alvotech is currently generating about -0.05 per unit of risk. If you would invest  88.00  in Assertio Therapeutics on August 28, 2024 and sell it today you would earn a total of  13.00  from holding Assertio Therapeutics or generate 14.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Assertio Therapeutics  vs.  Alvotech

 Performance 
       Timeline  
Assertio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Assertio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Alvotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Alvotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Alvotech is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Assertio Therapeutics and Alvotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Assertio Therapeutics and Alvotech

The main advantage of trading using opposite Assertio Therapeutics and Alvotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Assertio Therapeutics position performs unexpectedly, Alvotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvotech will offset losses from the drop in Alvotech's long position.
The idea behind Assertio Therapeutics and Alvotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios